Table 2.
Characteristics of target lesions.
| Site | n(%) | Tumor size(ml)* | Prescribed dose(Gy)* | Number of fractions* | Dose per fraction(Gy)* | BED10(Gy)* |
|---|---|---|---|---|---|---|
| Lung | 46 (35) | 6.5 (0.2-23.7) | 45 (15-60) | 3 (1-9) | 18 (6.67-33) | 130.2 (37.5-180) |
| Bone | 43 (32) | 22.9 (1.2-118.3) | 30 (15-40) | 3 (1-5) | 10 (7-22) | 60 (35.7-89.7) |
| Lymph node | 17 (13) | 27.0 (4.2-152.3) | 40 (36-55) | 5 (3-10) | 8 (5.5-13) | 79.2 (65.625-102.6) |
| Adrenal gland | 14 (11) | 46.9 (14.9-100.1) | 40 (35-45) | 5 (3-5) | 9 (7-15) | 85.5 (59.5-112.5) |
| Liver allograft | 8 (6) | 11.7 (4.4-57.0) | 45 (36-45) | 3 (3-5) | 13.5 (8-15) | 99 (72-112.5) |
| Brain | 2 (1) | 20.3 (8.2-32.5) | 37.5 (35-40) | 5 (5-5) | 7.5 (7-8) | 65.75 (59.5-72) |
| Other (Spleen/Chest wall/Diaphragm) | 3 (2) | 74.0 (50.5-131.3) | 40 (40-55) | 5 (3-9) | 8 (6.1-15) | 88.61 (72-112.5) |
*median (range).